Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse - Test2 - elhamkhani - TriplyDB

Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse

Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse

http://www.wikidata.org/entity/Q36024183

about

Marijuana: current concepts(†)Pharmacotherapies for cannabis dependence State of the art treatments for cannabis dependence Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC Pharmacotherapy for cannabis dependence: how close are we?Progress toward pharmacotherapies for cannabis-use disorder: an evidence-based review Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review Cannabinoid abuse and addiction: Clinical and preclinical findings The cannabis withdrawal syndrome: current insights Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders A review of human drug self-administration procedures.Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge Cognitive function as an emerging treatment target for marijuana addiction Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers.BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.New Developments in Understanding and Treating Adolescent Marijuana Dependence Quantifying the clinical significance of cannabis withdrawal Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?Cannabis use disorder: epidemiology and management.Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from Ecological Momentary Assessment.Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial Pharmacological treatment of cannabis dependence.Immediate antecedents of marijuana use: an analysis from ecological momentary assessment.Cannabis and psychopathology: The meandering journey of the last decade Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone.Marijuana's acute effects on cognitive bias for affective and marijuana cues.A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study Marijuana dependence: not just smoke and mirrors.Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.

P2860

Q21090461-58752695-FCF1-45BA-B098-A384DA46054A Q24187250-12DB5009-49EA-420E-99C0-3DE83CECC132 Q24607810-8C113795-5588-416E-89BC-D08A8FF0D2E7 Q24634909-C93BCAC3-181F-4106-B731-AFC7D44222A0 Q24648976-F6ED0F53-EC88-450D-AC8F-2CA9442DAD80 Q26746192-41EFC0D6-A7F1-4780-A75C-B94DCAEF6E90 Q26749602-109693E4-F23E-44D9-8D6D-25A6EDDDCB5C Q26851944-01DA7814-5D8A-45C2-B2F0-EED33CF790C8 Q30313180-9E3CDFED-9E26-446C-AA77-6A62D3AEDDDC Q33624781-051817D1-B5BD-430F-9965-D7E4212A6D5C Q33736941-5FA4A311-6C5B-4AC8-AEAA-F46CEAFBFEF4 Q33841805-10EA0605-E025-4557-B1A6-397EF59A983D Q33915426-B1A53949-0E1A-4DAD-A9D6-B099960C7D21 Q34018386-6DB4174D-38D5-4901-9B60-280094722B35 Q34028114-FE5A12EE-A30A-4045-A4BC-DD1D43221F99 Q34091534-84FF608E-8738-4F37-80A7-44A7D6391C29 Q34277168-DCAF7A8D-ADE9-474C-A432-9B224816A273 Q34288989-97CB6481-90F2-40CF-BFA9-EEBFFB06C903 Q34437940-8A117B57-F73D-4A34-AA50-9980C9DC9633 Q34615910-A117BDFB-6F79-440A-AC28-2BF978DFE377 Q34975761-266CED8E-CD69-45BD-A8BC-A595D1CFECD6 Q35005766-8109EBF7-04E7-4F9F-BE96-C7EDA0EABF9B Q35160234-846A0088-AACD-4D06-B349-EE8CC33C0B75 Q35210350-0486C347-8F19-4D1F-AF75-34E8D5795CA1 Q35620585-5AB80EC0-DA19-4C8B-860B-F14D2C98478C Q35716762-D09666E0-4ACC-4D55-A11B-91A8B024E702 Q35881015-43DCBE1B-EAB0-41BF-8917-F67D32E08B7F Q35887456-71F6865C-468F-4D0F-ADDC-5C374D527705 Q35911283-01BC4FE0-64EA-4167-AF70-CF4B8293EF19 Q35952033-F14DA94A-FBB0-4377-8BEE-7773F4A1BEE5 Q36083421-D0989CF5-E1E1-4494-B9DD-6072C95BF71C Q36301495-E1A7556A-E12D-4A3E-9CA7-C0286A7405CD Q36468008-223B23E4-3803-4637-B447-0791D5C88FB0 Q36509285-FF2969C0-7F65-490F-BDCE-871E6802732F Q36536527-7ECEAB3C-D6F9-4815-BB54-380A1CFA02D5 Q36567126-24644C0E-5F1F-4825-8C78-D02F8D5427CD Q36712200-619447D4-489C-43A3-91E6-13424C5418A6 Q36801465-0EA58FB3-3F84-483D-8D8A-D16849C87577 Q36927776-7AD2428A-E798-4EFC-80A3-187B166787FB Q36932158-D8923830-EB8F-4A03-9B43-3EADDA138222

P2860

Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse

http://www.wikidata.org/entity/Q36024183

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Effects of THC and lofexidine ...... rijuana withdrawal and relapse

@ast

Effects of THC and lofexidine ...... rijuana withdrawal and relapse

@en

type

label

Effects of THC and lofexidine ...... rijuana withdrawal and relapse

@ast

Effects of THC and lofexidine ...... rijuana withdrawal and relapse

@en

prefLabel

Effects of THC and lofexidine ...... rijuana withdrawal and relapse

@ast

Effects of THC and lofexidine ...... rijuana withdrawal and relapse

@en

P1433

Q36024183-0B4F1933-ACC8-466F-87D2-991A8437A3DB

P1476

Q36024183-5CBB6810-7E2B-424E-9157-330958C4C08A

P2093

Q36024183-0F70754D-A24D-4B32-ACEC-347C850FDBA2

Q36024183-48721206-658A-4868-A22E-D1BCCB1D9C92

Q36024183-6E3054D1-D67A-4F4E-9E99-24062AE6F257

Q36024183-9C14AE20-74B0-48D6-AD47-E87DFA7B4004

Q36024183-D6E7B84F-6DE3-40BF-865C-28CA7F0EBEA7

Q36024183-F10A8AF8-8C3D-4DBC-8115-81B56FC49D57

P2860

Q36024183-0AFAED85-66A9-4264-973A-AE4A346360B3

Q36024183-1087B469-991F-4A8E-A37E-B2883F870FD8

Q36024183-12E0C6BE-B9F1-416A-8A84-060E00B22209

Q36024183-1B6F7F7A-641D-4B35-B082-64FDF6CBED4A

Q36024183-2646131B-AC8A-42AE-A4EC-5E33C045B3E3

Q36024183-29F37B5C-DFF7-4147-A70F-5BE867A63D47

Q36024183-3415542D-F8C1-4814-9468-B18032779D97

Q36024183-36C11F19-9ECF-4941-8F55-F77DB029CF15

Q36024183-3BE6B6A3-C2BF-49AF-B643-347B2D6AAA0C

Q36024183-3C21EEAD-DE8E-4872-9FFF-A69C80DC1BF1

P2888

Q36024183-029CE86D-C6C6-4707-AA73-D806B71D78D7

P304

Q36024183-C052CA5C-A7A1-4805-9630-AD4EB4DA2C6B

P31

Q36024183-499FB948-FC38-40EB-8043-EBDA5FBC1016

P356

Q36024183-47EBBC5A-09A4-4207-ACAB-762A783BB69B

P433

Q36024183-DE048E2D-323B-42F7-A60E-08E134380968

P478

Q36024183-8C4AA2E8-D494-47A4-9841-46C16D860E60

P577

Q36024183-EB4C8BCA-D13D-4681-82ED-BDEDA4885042

P5875

Q36024183-1D0D49BD-BD18-427F-BCE1-FDBF0F9593F0

P698

Q36024183-025B1C84-64A5-4631-8C48-F53A8EBCDBE2

P932

Q36024183-E76780EE-B145-4D8A-BAD0-756A36D36CBD

P356

S00213-007-1020-8

P1433

Psychopharmacology

P1476

Effects of THC and lofexidine ...... rijuana withdrawal and relapse

@en

P2093

Carl L Hart

http://www.w3.org/2001/XMLSchema#string

Margaret Haney

http://www.w3.org/2001/XMLSchema#string

Richard W Foltin

http://www.w3.org/2001/XMLSchema#string

Sandra D Comer

http://www.w3.org/2001/XMLSchema#string

Stephanie Collins Reed

http://www.w3.org/2001/XMLSchema#string

Suzanne K Vosburg

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology

The reinstatement model of drug relapse: history, methodology and major findings

Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.

Advances in non-nicotine pharmacotherapy for smoking cessation.

Abstinence symptoms during withdrawal from chronic marijuana use.

Marijuana abstinence effects in marijuana smokers maintained in their home environment.

Marijuana withdrawal in humans: effects of oral THC or divalproex.

The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers.

Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies.

Implications of methadone maintenance for theories of narcotic addiction.

P2888

s00213-007-1020-8

P304

157-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00213-007-1020-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5688442

http://www.w3.org/2001/XMLSchema#string

P698

18161012

http://www.w3.org/2001/XMLSchema#string

P932

3372576

http://www.w3.org/2001/XMLSchema#string